Kythera Biopharmaceuticals
Focuses on the discovery, development, and commercialization of prescription products for the aesthetic medicine market in the United States and internationally.
Launch date
Employees
Market cap
-
Enterprise valuation
$2.1b (Public information from Jun 2015)
Calabasas California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$1.0m | Seed | ||
$10.0m | Series B | ||
$30.0m | Series C | ||
$37.4m | Series D | ||
| N/A | $70.4m | IPO | |
* | N/A | $112m | Post IPO Equity |
$2.1b Valuation: $2.1b | Acquisition | ||
| Total Funding | $78.4m | ||